Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (801-810 of 993) with videos related to

Pageof 100
Sort By:
Anticancer Research|October 26, 2022
Hispanic <i>vs.</i> Caucasian Race/Ethnicity in Adrenocortical Carcinoma PatientsAndrea Panunzio, Stefano Tappero, Cristina Cano Garcia, et al.
Prostate Cancer and Prostatic Diseases|February 24, 2022
Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in CanadaBobby Shayegan, Christopher J D Wallis, Robert J Hamilton, et al.
The Lancet. Oncology|August 13, 2021
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trialJohann S de Bono, Niven Mehra, Giorgio V Scagliotti, et al.
Journal of Clinical Medicine|March 11, 2023
The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in Non-Urothelial Variant-Histology Bladder CancerRocco Simone Flammia, Antonio Tufano, Francesco Chierigo, et al.
European Urology Oncology|July 17, 2025
Years of Life Lost in Metastatic and Locally Advanced Prostate CancerFabian Falkenbach, Quynh Chi Le, Mattia Longoni, et al.
Clinical Genitourinary Cancer|January 25, 2025
Clinically Meaningful Upstaging and Upgrading in Favorable Intermediate-Risk Radical Prostatectomy PatientsMattia Longoni, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
Current Urology|August 23, 2024
The association of type and number of high-risk criteria with cancer-specific mortality in prostate cancer patients treated with radical prostatectomyFrancesco Chierigo, Rocco Simone Flammia, Gabriele Sorce, et al.
Cancers|April 13, 2024
Non-Surgical Bladder-Sparing Multimodal Management in Organ-Confined Urothelial Carcinoma of the Urinary Bladder: A Population-Based AnalysisMario de Angelis, Andrea Baudo, Carolin Siech, et al.
Annals of Surgical Oncology|March 25, 2024
Perioperative Complications and In-Hospital Mortality in Partial and Radical Nephrectomy Patients with Heart-Valve ReplacementCarolin Siech, Andrea Baudo, Mario de Angelis, et al.
Annals of Surgical Oncology|February 20, 2026
Cancer-Specific Mortality in Rare Histological Subtypes of Prostate Cancer: Radical Prostatectomy Versus Radiation TherapyCarolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
Pageof 100

Showing results (801-810 of 993) with videos related to

Sort By:
Pageof 100
Anticancer Research|October 26, 2022
Hispanic <i>vs.</i> Caucasian Race/Ethnicity in Adrenocortical Carcinoma PatientsAndrea Panunzio, Stefano Tappero, Cristina Cano Garcia, et al.
Prostate Cancer and Prostatic Diseases|February 24, 2022
Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in CanadaBobby Shayegan, Christopher J D Wallis, Robert J Hamilton, et al.
The Lancet. Oncology|August 13, 2021
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trialJohann S de Bono, Niven Mehra, Giorgio V Scagliotti, et al.
Journal of Clinical Medicine|March 11, 2023
The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in Non-Urothelial Variant-Histology Bladder CancerRocco Simone Flammia, Antonio Tufano, Francesco Chierigo, et al.
European Urology Oncology|July 17, 2025
Years of Life Lost in Metastatic and Locally Advanced Prostate CancerFabian Falkenbach, Quynh Chi Le, Mattia Longoni, et al.
Clinical Genitourinary Cancer|January 25, 2025
Clinically Meaningful Upstaging and Upgrading in Favorable Intermediate-Risk Radical Prostatectomy PatientsMattia Longoni, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
Current Urology|August 23, 2024
The association of type and number of high-risk criteria with cancer-specific mortality in prostate cancer patients treated with radical prostatectomyFrancesco Chierigo, Rocco Simone Flammia, Gabriele Sorce, et al.
Cancers|April 13, 2024
Non-Surgical Bladder-Sparing Multimodal Management in Organ-Confined Urothelial Carcinoma of the Urinary Bladder: A Population-Based AnalysisMario de Angelis, Andrea Baudo, Carolin Siech, et al.
Annals of Surgical Oncology|March 25, 2024
Perioperative Complications and In-Hospital Mortality in Partial and Radical Nephrectomy Patients with Heart-Valve ReplacementCarolin Siech, Andrea Baudo, Mario de Angelis, et al.
Annals of Surgical Oncology|February 20, 2026
Cancer-Specific Mortality in Rare Histological Subtypes of Prostate Cancer: Radical Prostatectomy Versus Radiation TherapyCarolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
Pageof 100